InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Hausman Diana. Officer active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 4 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €47k. History available since 8 May 2023. The latest transaction was filed on 2 July 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
HAUSMAN DIANA is Chief Medical Officer at Zentalis Pharmaceuticals, Inc. (XNAS) and Director at Immuneering Corp (XNAS). Across 4 filings, the recent filings we hold run from 2023-05-10 to 2025-07-07, with EUR 7,618 of buys and EUR 39,269 of sells in that sampled set.